AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

ISREC-SCCL Symposium 2023 | Registration is now open!

Register

Events

AGORA PRS | February 7th

More information

Highlighted publication

Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.

Álvarez-Prado ÁF, Maas RR, Soukup K, (…), Daniel RT, Hegi ME, Joyce JA

Cell reports. Medicine – 2023 Jan 17

Highlighted publication

Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8⁺ T cells and reprogramming macrophages

Tichet M, Wullschleger S, Chryplewicz A, (…), Umaña P, Klein C, Hanahan D

Immunity – 2023 Jan 10

News

AGORA Tumor Microenvironment Journal Club | February 16th

Highlight

Energy crisis: How you can contribute to reduce consumption

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Andrea Alimonti | February 23rd

More information

News

Prof Simon & PD Dr Tolstonog receive SNSF SINERGIA grant

News

Fondazione San Salvatore funding awarded to Dr Herrera

News

Prof. Migliorini receives SNSF BRIDGE Discovery funding

Highlight

Highly cited researchers 2022

Events

AGORA Single-cell omics meetings

More information

Past news

Latest publications

Contemplating immunopeptidomes to better predict them

Gfeller D, Liu Y, Racle J

Seminars in Immunology – 2023 Mar 1

Design and construction of a microfluidics workstation for high-throughput multi-wavelength fluorescence and transmittance activated droplet analysis and sorting.

Panwar J, Autour A, Merten CA

Nature protocols – 2023 Jan 27

[Oncology: what’s new in 2022].

Nguyen-Ngoc T, Abdelhamid K, Degrauwe N, (…), Zaman K, Peters S, Stravodimou A

Revue medicale suisse – 2023 Jan 18

Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.

Álvarez-Prado ÁF, Maas RR, Soukup K, (…), Daniel RT, Hegi ME, Joyce JA

Cell reports. Medicine – 2023 Jan 17

Towards next-generation TIL therapy: TILs enriched in neoepitope-specific T cells.

Arnaud M, Coukos G, Harari A

Clinical and translational medicine – 2023 Jan 13